logo
ProjectActive

Hikma expansion

The status, timeline and source of this project. A free account opens every field.

Source: International Finance Corporation (IFC)

Hikma Pharmaceuticals PLC (‘Hikma’, ‘the company’ or together with its subsidiaries ‘the Group’) is a generic pharmaceutical company incorporated in United Kingdom (UK) and listed on the London Stock Exchange. While the Group was founded in Jordan in 1978, Hikma has expanded its footprint with successful operations across the Middle East and North Africa (MENA) region, the United States (US) and E

Status
Prospective
Sector
Manufacturing (Industrial), Government, Hospital
Location
Jordan
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Hikma expansion

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Hikma expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Jordan. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Hikma Pharmaceuticals PLC (‘Hikma’, ‘the company’ or together with its subsidiaries ‘the Group’) is a generic pharmaceutical company incorporated in United Kingdom (UK) and listed on the London Stock Exchange. While the Group was founded in Jordan in 1978, Hikma has expanded its footprint with successful operations across the Middle East and North Africa (MENA) region, the United States (US) and Europe. The company has 29 manufacturing facilities in 11 countries of which facilities in 5 countries have received approval from the US Food and Drug Administration (FDA). Hikma’s main business lines include branded, injectable and generic pharmaceuticals. Hikma is a long-standing IFC client since 1987 whereby support was primarily provided to the company’s investments in the MENA region including financing of acquisition in Algeria, Tunisia and Morocco and Egypt, allied to expansion of existing facilities.  The current investment involves; i) an A Loan of up to $150 million; and ii) syndicated parallel loans of an amount to be determined to the company for general purposes of the company and members of its Group in the MENA region and other developing countries in which Hikma operates.

Original sector

G-FA - Pharmaceuticals and Medicine

Location

Country

Jordan

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Government, Hospital

Article published date

2025-09-10

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project